Sichuan Biokin PharmaceuticalLtd Balance Sheet Health
Financial Health criteria checks 6/6
Sichuan Biokin PharmaceuticalLtd has a total shareholder equity of CN¥4.2B and total debt of CN¥1.5B, which brings its debt-to-equity ratio to 36.2%. Its total assets and total liabilities are CN¥7.0B and CN¥2.7B respectively. Sichuan Biokin PharmaceuticalLtd's EBIT is CN¥4.0B making its interest coverage ratio -34.5. It has cash and short-term investments of CN¥5.0B.
Key information
36.2%
Debt to equity ratio
CN¥1.54b
Debt
| Interest coverage ratio | -34.5x |
| Cash | CN¥4.98b |
| Equity | CN¥4.24b |
| Total liabilities | CN¥2.72b |
| Total assets | CN¥6.96b |
Recent financial health updates
Recent updates
Solid Earnings Reflect Sichuan Biokin PharmaceuticalLtd's (SHSE:688506) Strength As A Business
Nov 04
Getting In Cheap On Sichuan Biokin Pharmaceutical Co.,Ltd. (SHSE:688506) Is Unlikely
Oct 29Sichuan Biokin PharmaceuticalLtd (SHSE:688506) Could Easily Take On More Debt
Aug 17Sichuan Biokin PharmaceuticalLtd's (SHSE:688506) Earnings May Just Be The Starting Point
May 03Financial Position Analysis
Short Term Liabilities: 688506's short term assets (CN¥6.1B) exceed its short term liabilities (CN¥2.1B).
Long Term Liabilities: 688506's short term assets (CN¥6.1B) exceed its long term liabilities (CN¥649.9M).
Debt to Equity History and Analysis
Debt Level: 688506 has more cash than its total debt.
Reducing Debt: 688506's debt to equity ratio has reduced from 47.6% to 36.2% over the past 5 years.
Debt Coverage: 688506's debt is well covered by operating cash flow (283.8%).
Interest Coverage: 688506 earns more interest than it pays, so coverage of interest payments is not a concern.